Deferasirox Tablet, Film Coated
Product Images NDC 67877-552

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 67877-552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferasirox 180mg 30tab

Deferasirox Tablets 180 mg per tablet film-coated oral tablets packaging label displaying the active ingredient Deferasirox 180 mg. The label includes storage instructions, manufacturer Alkem Laboratories Ltd., distributor Ascend Laboratories LLC, barcode, and package count of 30 tablets. The label indicates 'Rx Only' and instructs pharmacists to dispense the medication guide with each patient.*

FDA Label Image

Deferasirox 360mg 30tab

Deferasirox Tablets 360 mg per tablet film-coated oral tablets label. The label displays NDC 67877-554-30 and packaging for 30 tablets. Instructions for storage at 20°C to 25°C and warnings to keep out of reach of children are included. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. The Ascend Laboratories logo is also visible.*

FDA Label Image

Deferasirox 90mg 30tab

Label for Deferasirox Tablets, 90 mg per tablet, film-coated oral dosage form. The label indicates a package size of 30 tablets and is distributed by Ascend Laboratories, LLC. Manufacturing is by Alkem Laboratories Ltd., India. Includes storage instructions and a note for pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Deferasirox Fig

A bar graph showing the effect of different doses of Deferasirox (5, 10, 20, 30 mg/kg/day) on liver iron content (mg Fe/g dry weight) and serum ferritin (mcg/L). Liver iron content is represented with white bars, and serum ferritin with black bars, each indicating changes at various dose levels with sample sizes noted below each bar group.*

FDA Label Image

Deferasirox St

Chemical structure of deferasirox, showing its molecular framework with multiple aromatic rings and hydroxyl groups, corresponding to the active ingredient in the Deferasirox film-coated tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.